
Sign up to save your podcasts
Or


Most commonly known psychedelics are considered schedule 1 substances by the controlled substances act, meaning they is no currently accepted medical use and a high potential for abuse. However, there is emerging evidence that psychedelics may have some therapeutic value. Dr. Matthew Johnson discusses the history of psychedelic research in the United States and his work on understanding abuse potential and therapeutic value of one specific psychedelic, psilocybin. Matt is the Susan Hill Ward Professor in Psychedelics and Consciousness and Professor of Psychiatry and Behavioral Sciences at Johns Hopkins.
By Samuel Acuff and Noah Emery4.5
3939 ratings
Most commonly known psychedelics are considered schedule 1 substances by the controlled substances act, meaning they is no currently accepted medical use and a high potential for abuse. However, there is emerging evidence that psychedelics may have some therapeutic value. Dr. Matthew Johnson discusses the history of psychedelic research in the United States and his work on understanding abuse potential and therapeutic value of one specific psychedelic, psilocybin. Matt is the Susan Hill Ward Professor in Psychedelics and Consciousness and Professor of Psychiatry and Behavioral Sciences at Johns Hopkins.

91,208 Listeners

43,587 Listeners

39,186 Listeners

778 Listeners

2,752 Listeners

113,290 Listeners

56,909 Listeners

627 Listeners

1,366 Listeners

4,052 Listeners

8,049 Listeners

637 Listeners

29,325 Listeners

16,498 Listeners

632 Listeners